Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Leon Gerardus Joseph Frenken is active.

Publication


Featured researches published by Leon Gerardus Joseph Frenken.


Protein Science | 2009

Single-domain antibody fragments with high conformational stability

Mireille Dumoulin; Katja Conrath; Annemie Van Meirhaeghe; Filip Meersman; Karel Heremans; Leon Gerardus Joseph Frenken; Serge Muyldermans; Lode Wyns; André Matagne

A variety of techniques, including high‐pressure unfolding monitored by Fourier transform infrared spectroscopy, fluorescence, circular dichroism, and surface plasmon resonance spectroscopy, have been used to investigate the equilibrium folding properties of six single‐domain antigen binders derived from camelid heavy‐chain antibodies with specificities for lysozymes, β‐lactamases, and a dye (RR6). Various denaturing conditions (guanidinium chloride, urea, temperature, and pressure) provided complementary and independent methods for characterizing the stability and unfolding properties of the antibody fragments. With all binders, complete recovery of the biological activity after renaturation demonstrates that chemical‐induced unfolding is fully reversible. Furthermore, denaturation experiments followed by optical spectroscopic methods and affinity measurements indicate that the antibody fragments are unfolded cooperatively in a single transition. Thus, unfolding/refolding equilibrium proceeds via a simple two‐state mechanism (N⇋U), where only the native and the denatured states are significantly populated. Thermally‐induced denaturation, however, is not completely reversible, and the partial loss of binding capacity might be due, at least in part, to incorrect refolding of the long loops (CDRs), which are responsible for antigen recognition. Most interestingly, all the fragments are rather resistant to heat‐induced denaturation (apparent Tm = 60–80°C), and display high conformational stabilities (ΔG(H2O) = 30–60 kJ mole−1). Such high thermodynamic stability has never been reported for any functional conventional antibody fragment, even when engineered antigen binders are considered. Hence, the reduced size, improved solubility, and higher stability of the camelid heavy‐chain antibody fragments are of special interest for biotechnological and medical applications.


Archive | 1994

ScFv Antibody Fragments Produced in Saccharomyces cerevisiae Accumulate in the Endoplasmic Reticulum and the Vacuole

Leon Gerardus Joseph Frenken; Eveline van Tuijl; J. Wil Bos; Wally H. Müller; Arie J. Verkleij; C. Theo Verrips

The yeast Saccharomyces cerevisiae has a number of properties which makes it an important organism for the production of heterologous proteins for research, medical and industrial use. Yeast is particularly amenable to genetic manipulation and a number of auxotrophic markers and strong (inducible) promoters are known. It can secrete proteins into the culture medium and, in contrast to prokaryotes, it can also glycosylate proteins, which is of particular importance for the production of heterologous eukaryotic proteins, which are glycosylated by their naturel hosts. Yeast can grow rapidly on simple, inexpensive media to high cell densities, and knowledge on large scale fermentation and downstream processing is extensive. Furthermore, as it has been used in the brewing and baking industries for a long time, it has become a GRAS (Generally Regarded As Safe) organism. So far, it has been successfully used for the production of a number of single-chain heterologous proteins (Romanos et al.,1992).


Archive | 1994

Production of antibodies or (functionalized) fragments thereof derived from heavy chain immunoglobulins of camelidae

Raymond Hamers; Cécile Hamers-Casterman; Serge Muyldermans; Leon Gerardus Joseph Frenken; Cornelis Theodorus Verrips


Archive | 1995

Modified pseudomonas lipases and their use

Leon Gerardus Joseph Frenken; Hans Peters; Hildegard Maria Ursula Suerbaum; Vlieg Jakob De; Cornelis Theodorus Verrips


Archive | 1994

Immobilized proteins with specific binding capacities and their use in processes and products

Leon Gerardus Joseph Frenken; Pieter De Geus; Franciscus Maria Klis; Holger York Toschka; Cornelis Theodorus Verrips


Archive | 2000

Inhibition of viral infection using monovalent antigen-binding proteins

Sandra Bezemer; Leon Gerardus Joseph Frenken; Haard Johannes Joseph Wilhelmus De; Adrianus Marinus Ledeboer; Cornelis Theodorus Verrips


Archive | 1994

Process for producing fusion proteins comprising scfv fragments by a transformed mould

Leon Gerardus Joseph Frenken; Gorcom Robert F M Van; Johanna G. M. Hessing; Den Hondel Cornelis Antonius M. J. J. Van; Wouter Musters; Johannes Maria A Verbakel; Cornelis Theodorus Verrips


Archive | 1999

Products comprising inactivated yeasts or moulds provided with active antibodies

Leon Gerardus Joseph Frenken; Michael Marie Harmsen; Richard H.J van der Linden; Cornelis Theodorus Verrips


Archive | 1993

Production of active Pseudomonas glumae lipase in homologous or heterologous hosts

Jannetje Wilhelmina Unilev Bos; Leon Gerardus Joseph Frenken; Cornelis Theodorus Verrips; Christiaan Visser


Archive | 1995

Microbial lipase muteins and detergent compositions comprising same

Amir Maximiliaan Uni Batenburg; Maarten Robert Egmond; Leon Gerardus Joseph Frenken; Cornelis Theodorus Verrips

Collaboration


Dive into the Leon Gerardus Joseph Frenken's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Serge Muyldermans

Vrije Universiteit Brussel

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sandra Bezemer

Thermo Fisher Scientific

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Raymond Hamers

Vrije Universiteit Brussel

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge